Amsterdam 2013 Programme Satellite Meetings Registration Exhibition Virtual Exhibition Hotels Visa Letter Invitation
Search Abstracts by author or title
(results will display both Free Papers & Poster)

Multicentre observational registry: clinical experience with the WIOL-CF® intraocular lens

Poster Details

First Author: D.Sivekova CZECH REPUBLIC

Co Author(s):    J. Urminsky   P. Studeny   T. Novotny        

Abstract Details


Clinical evaluation of functional results and quality of vision after bilateral implantation of a bioanalogic, polyfocal, accommodative intraocular lens WIOL-CF®


Department of Ophthalmology, University Hospital Kralovske Vinohrady and 3rd Medical Faculty Prague, Czech Republic


The WIOL-CF® bioanalogic, polyfocal, accommodative IOL (MEDICEM) were implanted bilaterally after phacoemulsification with max. 2 weeks between the first and second eye implantation. Patient with any other ophthalmic pathology were excluded. Follow-up examinations were performed two weeks and three months after surgery including uncorrected and corrected visual acuity (VA) for far, near and intermediate distances, subjective refraction, contrast sensitivity under different lighting conditions and amplitude of accommodation. The quality of vision, glare, halos, spectacle independence and the personal satisfaction of the patients was assessed with a questionnaire.


First 18 cataract patients (36 eyes) from 7 centers have been enrolled in this non-interventional, multicentre, prospective observational registry. Mean age 63.1 years, median 61 years. Three months after implantation mean uncorrected distance VA was 0.97 and 100% of patients are better than 0.8. Mean uncorrected near VA J2.9. Patients contrast sensitivity results was above population norm for age 50-75 years. 89% patients did not need glasses for daily activities, driving and reading and 100% expressed subjective satisfaction as “very satisfied” or “satisfied”. Only one patient reported serious/disturbing glare and halo optical phenomena (5,6%).


The WIOL-CF® IOL provides very good and predictable functional results after surgery and should be considered as very promising IOL for refractive and cataract surgery, correcting presbyopia.

Financial Disclosure:


Back to previous